Last reviewed · How we verify
A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution
The purpose of this study was to assess the pigmentation in the trabecular meshwork of patients who had been treated for at least 2 years with TRAVATAN compared with patients without exposure (or less than 1 month) to a prostaglandin analogue (PGA).
Details
| Lead sponsor | Alcon Research |
|---|---|
| Status | TERMINATED |
| Enrolment | 88 |
| Start date | 2004-07 |
| Completion | 2012-02 |
Conditions
- Open-angle Glaucoma
Interventions
- Trabecular Meshwork Tissue Collection
- Travoprost 0.004% ophthalmic solution
Primary outcomes
- Melanin Granule Count — Day 1
A trabecular meshwork tissue sample was collected by the investigator. The number of pigment granules was counted for three separate microscopic fields of view. Mean melanin granule count was calculated.